Understanding why some racial and ethnic groups are less likely to get lung cancer screenings
Multilevel Determinants of Racial/Ethnic Disparities in Lung Cancer Screening Utilization
This study is looking into why fewer people, especially from different racial and ethnic backgrounds, are getting screened for lung cancer, and it aims to find ways to make these important screenings more accessible for everyone at risk.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Kaiser Foundation Research Institute NIH-funded |
| Lab location | 1 site (Oakland, UNITED STATES) |
| Project ID | NIH-11134647 on NIH RePORTER |
What this research studies
This research investigates the reasons behind the low utilization of lung cancer screenings, particularly among racial and ethnic minorities. It aims to identify various factors at individual, neighborhood, provider, and health facility levels that influence whether high-risk individuals receive these screenings. By analyzing electronic health records and other data sources, the study seeks to uncover barriers to screening and improve access for disadvantaged populations. The ultimate goal is to enhance lung cancer screening rates and reduce disparities in lung cancer outcomes.
Who could benefit from this research
Good fit: Ideal candidates for this research are high-risk individuals aged 21 and older, particularly those from racial and ethnic minority groups with a history of smoking.
Not a fit: Patients who do not have a history of smoking or are not considered high-risk for lung cancer may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved access to lung cancer screenings for racial and ethnic minorities, potentially reducing lung cancer mortality in these populations.
How similar studies have performed: Previous research has shown that addressing multilevel factors can improve health outcomes in disadvantaged populations, suggesting that this approach may be effective.
Where this research is happening
Oakland, UNITED STATES
- Kaiser Foundation Research Institute — Oakland, United States (Active)
Researchers
- Principal investigator: Sakoda, Lori — Kaiser Foundation Research Institute
- Study coordinator: Sakoda, Lori
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.